Pharmacological Inhibition of Insulin Growth Factor-1 Receptor (IGF-1R) Alone or in Combination With Ruxolitinib Shows Therapeutic Efficacy in Preclinical Myeloproliferative Neoplasm Models.

Basu, Titiksha; Bertrand, Hannah; Karantzelis, Nikolaos; Gründer, Albert; Pahl, Heike L

Basu, Titiksha; Bertrand, Hannah; Karantzelis, Nikolaos; Gründer, Albert; Pahl, Heike L.

Afiliação

Basu T; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Germany.
Bertrand H; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Germany.
Karantzelis N; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Germany.
Gründer A; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Germany.
Pahl HL; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Germany.

Hemasphere ; 5(5): e565, 2021 May.

Article em En | MEDLINE | ID: mdl-33954282

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Hemasphere Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google